miR-449a was implicated functionally in breast cancer pathogenesis, suppressing Cysteine-Rich Protein 2 (CRIP2) and altering cell viability, migration, invasion, in vivo tumor growth, and angiogenesis, thereby driving malignant phenotypes in these aggressive tumors. Here, CRIP2 is linked to breast carcinoma.